Moreover, we further identified ATPIF1 as a novel critical downstream effector of miR-148b-5p in GC even though one previous study demonstrated miR-29 regulating ATPIF1 level in breast cancer (21). This evidence concerns the gene ATP5IF1 and breast cancer.